SoftBank invests in a new USD 400m European tech fund of Mubadala
Category: #business  By Mateen Dalal  Date: 2019-02-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

SoftBank invests in a new USD 400m European tech fund of Mubadala

Mubadala would use the fund to invest between USD 5 million and USD 30 million in European technology startups

Japans conglomerate SoftBank Group has reportedly announced to have invested nearly half the amount for the recently launched USD 400 million technology fund by United Arab Emirates state-owned Mubadala Investment Company. As per trusted sources, the technology fund was unveiled last year by Mubadala Investment Company with an objective to back European startups.

Reportedly, the European venture fund would be operated from a new office in London. People with knowledge of the matter claim that the technology fund has already made a few undisclosed investments. A big investor in SoftBank’s Vision Fund, Mubadala Investment Company would utilize the fund to invest between USD 5 million and USD 30 million in European startups.

The launch of the European tech fund was made by Mubadala at London Tech Week last year. It was stated that Mubadala Ventures, the venture capital arm of Mubadala Investment Company, would manage the tech fund. Reportedly, Mubadala Ventures would also facilitate the process for European tech firms to build operations in Abu Dhabi to target the Middle East and Gulf markets.

Since its inception, SoftBank Group has participated as a strategic investor in the tech fund through its investment subsidiary, SIMI US Holdings I, Inc. The venture firm had released a statement during the launch which had noted that the fund would work closely with early-stage UK and other European funds. The firm would enlarge its fund of funds program as part of its European strategy and would invest in both emerging and established fund managers throughout the continent.

According to a report published by Channel NewsAsia, Mubadala was not immediately reachable for comment, while SoftBank did not respond to a request seeking comment.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

SpringWorks begins Phase 3 trial of desmoid tumor treatment in adults
SpringWorks begins Phase 3 trial of desmoid tumor treatment in adults
By Mateen Dalal

The company is looking forward to enrolling patients with desmoid tumors to confirm the clinical benefits of nirogacestat SpringWorks Therapeutics, a clinical-stage biopharmaceutical company, has reportedly announced the beginning of Phase 3 “...

Exelixis & Iconic Therapeutics ink exclusive license and option deal
Exelixis & Iconic Therapeutics ink exclusive license and option deal
By Mateen Dalal

The exclusive license & option agreement has been signed for a new Antibody-Drug conjugate program.   The program, named ICON-2, specifically targets Tissue Factor and would have a potential broad impact on oncology. Exelixis, Inc., (E...

JD.com invests $55 million to foster connected vehicle fleets
JD.com invests $55 million to foster connected vehicle fleets
By Mateen Dalal

The launch of logistic service has begun to reap early rewards regarding cost saving. The long-time rival of Alibaba and Amazon, JD.com, has reportedly announced to invest 376 million yuan (around $55 million) in Jiangsu Xinning Modern Logistics to ...